Sunrest Lifescience Ltd.
•₹ 41-2.73%
2026-08-21
PROS
- Working capital cycle has improved - days down from 247 to 170
- Company comfortably covers its interest (8.1x coverage)
CONS
- Operating cash flow has been negative in recent years
- Total debt has risen sharply - up 44.9% year on year
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | ADANIENT | 2979.00 | 54.17 | 403273.96 | 0.04 | -1461.54 | -249.67 | 32923.98 | 49.92 | 13.30 | 15.57 |
| 2. | AEGISLOG | 1363.65 | 38.25 | 47864.12 | 0.64 | 544.84 | 210.70 | 2356.86 | 37.07 | 19.76 | 30.28 |
| 3. | PREMIERENE | 1008.00 | 27.48 | 45758.31 | 0.10 | 471.92 | 53.32 | 2462.59 | 35.25 | 41.97 | 29.03 |
| 4. | CPPLUS | 3307.45 | 81.98 | 39127.28 | 0.05 | 142.20 | 332.51 | 1402.42 | 89.51 | 29.48 | 14.52 |
| 5. | REDINGTON | 334.90 | 15.39 | 26181.63 | 1.79 | 453.49 | 94.65 | 34922.47 | 34.57 | 18.96 | 2.03 |
| 6. | HONASA | 476.90 | 62.48 | 15548.09 | 0.63 | 90.45 | 118.87 | 755.95 | 27.00 | 8.99 | 14.58 |
| 7. | LLOYDSENT | 78.59 | 106.84 | 11997.17 | 0.19 | 109.98 | -55.77 | 563.03 | 70.15 | 12.84 | 18.07 |
| 8. | SGMART | 805.80 | 81.69 | 10155.92 | 0.00 | 455.80 | 1310.71 | 13085.70 | 1044.08 | 11.45 | 4.49 |
| 9. | MMTC | 62.10 | 20.82 | 9315.00 | 0.00 | 104.24 | 135.52 | 0.68 | -50.00 | 6.90 | -1423.53 |
| 10. | CELLO | 358.45 | 25.31 | 7917.62 | 0.42 | 73.40 | -8.99 | 526.72 | -0.43 | 17.15 | 18.80 |
| 11. | EBGNG | 588.80 | 47.13 | 6713.00 | 0.00 | 289.30 | 1462.10 | 4124.61 | 1220.81 | 20.14 | 11.97 |
| 12. | SUNREST | 40.90 | 8.53 | 35.10 | 0.00 | — | — | — | — | 34.78 | — |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 33 | 71 | |
| 30 | 61 | |
| Operating Profit | 3 | 13 |
| OPM % | 9 | 18 |
| Other Income | 0 | 3 |
| Interest | 0 | 1 |
| Depreciation | 0 | 1 |
| 3 | 10 | |
| Tax % | 23 | 21 |
| Net Profit | 2 | 8 |
| EPS | 5 | 10 |
| Dividend Payout % | 0 | 0 |
| Minority Interest | -0 | -4 |
| Share of Associates | 0 | 0 |
| Adjusted EPS | 5 | 10 |
| Minority Interest | -0 | -4 |
| Share of Associates | 0 | 0 |
| Adjusted EPS | 5 | 10 |
Mar 2025
- 33
- 30
- Operating Profit
- 3
- OPM %
- 9
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 3
- Tax %
- 23
- Net Profit
- 2
- EPS
- 5
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2026
- 71
- 61
- Operating Profit
- 13
- OPM %
- 18
- Other Income
- 3
- Interest
- 1
- Depreciation
- 1
- 10
- Tax %
- 21
- Net Profit
- 8
- EPS
- 10
- Dividend Payout %
- 0
- Minority Interest
- -4
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- -4
- Share of Associates
- 0
- Adjusted EPS
- 10
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -10%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- Last Year:
- 44%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| LIABILITIES | - | - |
| Equity Capital | 4 | 4 |
| 12 | 16 | |
| 6 | 5 | |
| Trade Payables | 23 | 21 |
| 13 | 25 | |
| Total Liabilities | 58 | 71 |
| ASSETS | - | - |
| 4 | 9 | |
| 10 | 17 | |
| 36 | 32 | |
| Cash & Bank | 2 | 3 |
| 6 | 10 | |
| Total Assets | 58 | 71 |
| Total Debt | 12 | 17 |
| Net Working Capital | 23 | 33 |
| Contingent Liabilities | 0 | 0 |
| Book Value per Share | 38.01 | 47.60 |
| Face Value | 10.00 | 10.00 |
| Total Debt | 12 | 17 |
| Net Working Capital | 23 | 33 |
| Contingent Liabilities | 0 | 0 |
| Book Value per Share | 38.01 | 47.60 |
| Face Value | 10.00 | 10.00 |
Mar 2025
- Equity Capital
- 4
- 12
- 6
- Trade Payables
- 23
- 13
- Total Liabilities
- 58
- 4
- 10
- 36
- Cash & Bank
- 2
- 6
- Total Assets
- 58
- Total Debt
- 12
- Net Working Capital
- 23
- Contingent Liabilities
- 0
- Book Value per Share
- 38.01
- Face Value
- 10.00
- Total Debt
- 12
- Net Working Capital
- 23
- Contingent Liabilities
- 0
- Book Value per Share
- 38.01
- Face Value
- 10.00
Mar 2026
- Equity Capital
- 4
- 16
- 5
- Trade Payables
- 21
- 25
- Total Liabilities
- 71
- 9
- 17
- 32
- Cash & Bank
- 3
- 10
- Total Assets
- 71
- Total Debt
- 17
- Net Working Capital
- 33
- Contingent Liabilities
- 0
- Book Value per Share
- 47.60
- Face Value
- 10.00
- Total Debt
- 17
- Net Working Capital
- 33
- Contingent Liabilities
- 0
- Book Value per Share
- 47.60
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 3 | -0 | |
| Cash from Investing | -1 | -3 |
| Cash from Financing | -0 | 4 |
| 1 | 1 | |
| Free Cash Flow | 3 | -5 |
| OCF / Net Profit | 1.45 | -0.01 |
| Cumulative 5-Year FCF | 0 | 0 |
| OCF / Net Profit | 1.45 | -0.01 |
| Cumulative 5-Year FCF | 0 | 0 |
Mar 2025
- 3
- Cash from Investing
- -1
- Cash from Financing
- -0
- 1
- Free Cash Flow
- 3
- OCF / Net Profit
- 1.45
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.45
- Cumulative 5-Year FCF
- 0
Mar 2026
- -0
- Cash from Investing
- -3
- Cash from Financing
- 4
- 1
- Free Cash Flow
- -5
- OCF / Net Profit
- -0.01
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.01
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| PER SHARE | - | - |
| EPS (₹) | 4.67 | 9.59 |
| Book Value (₹) | 38.01 | 47.60 |
| Dividend per Share (₹) | 0.00 | 0.00 |
| Cash EPS (₹) | 4.91 | 21.41 |
| PROFITABILITY | - | - |
| Operating Margin % | 9.04% | 14.41% |
| Net Margin % | 6.02% | 11.29% |
| ROE % | 12.33% | 43.52% |
| ROCE % | 10.33% | 34.78% |
| 3.45% | 12.37% | |
| EFFICIENCY | - | - |
| Debtor Days | 397 | 177 |
| Inventory Days | 105 | 69 |
| Payable Days | 417 | 181 |
| 85 | 65 | |
| FINANCIAL HEALTH | - | - |
| Debt to Equity (x) | 0.74x | 0.85x |
| Interest Coverage (x) | 9.58x | 8.12x |
| 1.73x | 2.12x | |
| GROWTH | - | - |
| Revenue Growth % | 0.00% | 111.99% |
| Operating Profit Growth % | 0.00% | 320.43% |
| Net Profit Growth % | 0.00% | 297.61% |
| 0.00% | 105.27% | |
| VALUATION | - | - |
| P/E (x) | 11.50x | 3.60x |
| P/B (x) | 1.32x | 0.72x |
| Dividend Yield % | 0.00% | 0.00% |
| 11.04x | 2.40x |
Mar 2025
- EPS (₹)
- 4.67
- Book Value (₹)
- 38.01
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.91
- Operating Margin %
- 9.04%
- Net Margin %
- 6.02%
- ROE %
- 12.33%
- ROCE %
- 10.33%
- 3.45%
- Debtor Days
- 397
- Inventory Days
- 105
- Payable Days
- 417
- 85
- Debt to Equity (x)
- 0.74x
- Interest Coverage (x)
- 9.58x
- 1.73x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 11.50x
- P/B (x)
- 1.32x
- Dividend Yield %
- 0.00%
- 11.04x
Mar 2026
- EPS (₹)
- 9.59
- Book Value (₹)
- 47.60
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 21.41
- Operating Margin %
- 14.41%
- Net Margin %
- 11.29%
- ROE %
- 43.52%
- ROCE %
- 34.78%
- 12.37%
- Debtor Days
- 177
- Inventory Days
- 69
- Payable Days
- 181
- 65
- Debt to Equity (x)
- 0.85x
- Interest Coverage (x)
- 8.12x
- 2.12x
- Revenue Growth %
- 111.99%
- Operating Profit Growth %
- 320.43%
- Net Profit Growth %
- 297.61%
- 105.27%
- P/E (x)
- 3.60x
- P/B (x)
- 0.72x
- Dividend Yield %
- 0.00%
- 2.40x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.